...run on my Crypto's of late...
...so I'm putting some of the profits into some undervalued stocks...
...EDT seems like a good bet with it being 35% off the financing price, and 50% off the price it was trading at, in the days leading up to the latest bought deal financing by AGP...all with quite heavy insider participation.
A few good things have happened since we last traded at these levels in 2018 and 2017
For example I believe that the last time we traded at these levels ... was well before:
- Baxter distribution contract (derisking of Tigris, and cost covering)
- Kellum hired as CMO
- "Confirmatory" Phase 3b, 2:1, baysian, open label Trial
- SAMI FDA & HC approvals
- Golden Hour seminal article by Ronco (advocating for EAA and PMX-HP)
- World Sepsis Alliance talk & keynote acknowledgement of Spectral at Vincenza
- US presidential push towards Home Dialysis
- Outset and NxStage valuations of > $ 2B for their HD pumps
- Possibe benefit of PMX in treatment of Covid recently acknowledged by Kellum
- Lots more RWE for PMX-HP
- some dosing rationale on why the Euphrates results could have been better even outside the new target sub-group (filter capcity, duration, # filters, etc.)
- a demonstrated appetite for blood filtration devices in the US (se AEMD and CTSO) - even ones far less advanced (in terms of FDA approval) than Spectral.
Nothing else negative has happened that I can determine, other than a continuation of the silence.
MM